CD8A and melanoma: In order to observe whether AsC can change the tumor immune microenvironment during the inhibition of lung cancer and melanoma, we examined the proportions of various immune cells in mouse tumor tissue cells, including CD4+ T cells, CD8+ T cells and Natural Killer (NK) cells.